GeneLink GNLKQ Stock
0 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
397.53K USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
500 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
GeneLink Price Chart
GeneLink GNLKQ Financial and Trading Overview
| GeneLink stock price | 0.0000 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 1.2K USD |
| Avg. Volume | 0 USD |
| Market Cap | 3.98K USD |
| Beta (5Y Monthly) | -141.16338 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GNLKQ Valuation Measures
| Enterprise Value | 1.06M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.002517354 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.673 |
| Enterprise Value/EBITDA | -0.505 |
Trading Information
GeneLink Stock Price History
| Beta (5Y Monthly) | -141.16338 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
GNLKQ Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 265.02M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2012 |
| Most Recent Quarter (mrq) | September 30, 2013 |
| Next Fiscal Year End | December 31, 2013 |
Profitability
| Profit Margin | -141.050% |
| Operating Margin (ttm) | -139.46% |
| Gross Margin | 19.40% |
| EBITDA Margin | -133.36% |
Management Effectiveness
| Return on Assets (ttm) | -69.12% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.58M USD |
| Revenue Per Share (ttm) | 0.006 USD |
| Quarterly Revenue Growth (yoy) | -30.69% |
| Gross Profit (ttm) | 464.68K USD |
| EBITDA | -2105842 USD |
| Net Income Avi to Common (ttm) | -2227257 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 127.56K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 1.19M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.344 |
| Book Value Per Share (mrq) | -0.012 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1131392 USD |
| Levered Free Cash Flow (ttm) | -1752195 USD |
Profile of GeneLink
| Country | United States |
| State | FL |
| City | Orlando |
| Address | 8240 Exchange Drive |
| ZIP | 32809 |
| Phone | 407-680-1150 |
| Website | https://www.genelinkbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.
Q&A For GeneLink Stock
What is a current GNLKQ stock price?
GeneLink GNLKQ stock price today per share is 0.0000 USD.
How to purchase GeneLink stock?
You can buy GNLKQ shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GeneLink?
The stock symbol or ticker of GeneLink is GNLKQ.
Which industry does the GeneLink company belong to?
The GeneLink industry is Biotechnology.
How many shares does GeneLink have in circulation?
The max supply of GeneLink shares is 0.
What is GeneLink Price to Earnings Ratio (PE Ratio)?
GeneLink PE Ratio is now.
What was GeneLink earnings per share over the trailing 12 months (TTM)?
GeneLink EPS is 0 USD over the trailing 12 months.
Which sector does the GeneLink company belong to?
The GeneLink sector is Healthcare.